Search Results - "Dolžan, V"

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium by van der Wouden, CH, Cambon‐Thomsen, A, Cecchin, E, Cheung, KC, Dávila‐Fajardo, CL, Deneer, VH, Dolžan, V, Ingelman‐Sundberg, M, Jönsson, S, Karlsson, MO, Kriek, M, Mitropoulou, C, Patrinos, GP, Pirmohamed, M, Samwald, M, Schaeffeler, E, Schwab, M, Steinberger, D, Stingl, J, Sunder‐Plassmann, G, Toffoli, G, Turner, RM, van Rhenen, MH, Swen, JJ, Guchelaar, H‐J

“…Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application into routine care remains limited. Opportunely, several…”
Get full text

Polymorphisms in antioxidant genes as predictive factors of radiotherapy late skin adverse events in breast cancer patients by Marinko, T., Stojanov Konda, J.T., Dolžan, V., Goričar, K.

Get full text

Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis by Grabar, P Bohanec, Rozman, B, Logar, D, Praprotnik, S, Dolzan, V

Get more information

Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis by BOHANEC GRABAR, P, LOGAR, D, TOMSIC, M, ROZMAN, B, DOLZAN, V

“…Glutathione S-transferases (GST); GST-mu1 (GSTM1), GST-pi1 (GSTP1) and GST-theta1 (GSTT1) have peroxidase activity towards cytotoxic metabolites produced in…”
Get full text

The Influence of Gene-Gene and Gene-Environment Interactions on the Risk of Asbestosis by Dodič-Fikfak, Metoda, Arnerić, Niko, Dolžan, Vita, Franko, Alenka

“…This study investigated the influence of gene-gene and gene-environment interactions on the risk of developing asbestosis. The study comprised 262 cases with…”
Get full text

PP06.14 – 2591: Antioxidative enzyme polymorphisms and sequelae after neonatal hypoxic-ischaemic brain injury by Rener-Primec, Z, Esih, K, Goričar, K, Dolžan, V

“…Objective To investigate the impact of common functional polymorphisms in antioxidative genes GPX1, SOD2 and CAT, associated with decreased capacity of defence…”
Get full text

The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma by Erčulj, N., Kovač, V., Hmeljak, J., Dolžan, V.

“…Platinum-based therapy is widely used in the treatment of malignant mesothelioma (MM); however, the efficacy and toxicity of platinum agents vary greatly…”
Get full text

Clinical–pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis by Jenko, B, Lusa, L, Tomsic, M, Praprotnik, S, Dolzan, V

“…We describe a novel approach to investigate and evaluate combined effect of a large number of clinical and pharmacogenetic factors on treatment outcome. We…”
Get full text

PO-1362 Genetic variability of homologous recombination repair genes and radiotherapy cardiotoxicity by Marinko, T., Dugar, F., Dolžan, V., Goričar, K.

Get full text

PO-1121 Polymorphisms in DNA repair genes and radiotherapy late adverse events in breast cancer patients by Marinko, T., Dugar, F., Dolžan, V., Goričar, K.

Get full text

331P miR-21 and miR-34a as biomarkers of radiotherapy skin adverse events in ductal carcinoma in situ by Marinko, T., Cvetkoska, A., Trampuž, S. Redenšek, Dolžan, V., Goričar, K.

Get full text

2815 Functional polymorphisms in antioxidant genes and occurrence of recurrent disease in patients with Hurthle cell carcinoma by Pilko, G, Krhin, B, Besic, N, Goricar, K, Dolzan, V

Get full text

The contribution of HLA‐DQB1 coding and QBP promoter alleles to anti‐Ro alone autoantibody response in systemic lupus erythematosus by Logar, D., Vidan‐Jeras, B., Dolžan, V., Božič, B., Kveder, T.

“…Objective. To analyse the influence of HLA‐DR, DQ and corresponding DQA1 and DQB1 promoter alleles (QAP and QBP) on the anti‐Ro alone autoantibody response in…”
Get full text

P.6.b.001 Influence of NLPR3 and CARD8 inflammasome on expression of alcohol related psychopathological symptoms in alcohol addicted subjects by Plemenitas, A, Kores Plesnicar, B, Dolzan, V

Get full text

P115 - Polymorphisms in antioxidant genes as predictive factors of radiotherapy late skin adverse events in breast cancer patients by Marinko, T., Stojanov Konda, J.T., Dolžan, V., Goričar, K.

Get full text

Genetic variability of PON1 and NT-proBNP levels after breast cancer radiotherapy by Marinko, T., Konda, J.T. Stojanov, Dolžan, V., Goričar, K.

Get full text

Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease by Petrič, Boštjan, Redenšek Trampuž, Sara, Dolžan, Vita, Gregorič Kramberger, Milica, Trošt, Maja, Maraković, Nikola, Goličnik, Marko, Bavec, Aljoša

“…Cognitive impairment is a common non-motor symptom of Parkinson's disease (PD), which often progresses to PD dementia. PD patients with and without dementia…”
Get full text

Liquid Biopsy Predicting Pancreatic Cancer Resection by Badovinac, D., Goričar, K., Lavrin, T., Zavrtanik, H., Dolžan, V., Lenassi, M., Tomažič, A.

Get full text

Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose by Herman, D, Locatelli, I, Grabnar, I, Peternel, P, Stegnar, M, Mrhar, A, Breskvar, K, Dolzan, V

“…Warfarin is an anticoagulant drug with narrow therapeutic index and high interindividual variability in dose requirement. S-warfarin is metabolized mainly by…”
Get full text

P.1.a.013 Acute onset schizophrenia: adenosine receptors polymorphisms – correlation with psychopathology and adverse effects of antipsychotics by Turcin, A, Dolzan, V, Kastelic, M, Kores Plesnicar, B

Get full text